论文部分内容阅读
免疫治疗已有80余年的历史,随着分子克隆技术的发展和应用,哮喘的特异性免疫治疗出现了许多新概念和新模式。本文对近两年来有关哮喘特异性免疫治疗机制的认识及研究动向作一回顾和展望。
Immunotherapy has been more than 80 years of history, with the development and application of molecular cloning technology, asthma-specific immunotherapy there have been many new concepts and new models. This article reviews and forecasts the understanding and research trends on the mechanisms of asthma-specific immunotherapy in the past two years.